CVS Health Ventures makes investment in Amalgam Rx
Amalgam Rx, a company that enables data-driven healthcare decision making, announced the participation of CVS Health Ventures in its Series B investment round.
The investment supports the scaling of Amalgam’s EHR-integrated clinical decision support platform to provide actionable information for health care providers for use at the point of care. Amalgam’s technology aligns and helps realize shared savings agreements between payers and HCPs.
“Our investment in Amalgam reflects our commitment to redefining health care by making care delivery simpler, more personalized and better connected,” said Vijay Patel, managing partner and co-founder of CVS Health Ventures, the company’s dedicated corporate venture capital platform. “Amalgam’s point-of-care decision making capabilities can help further enhance a data-driven model of integrated care, supporting both providers and patients.”
[Read more: CVS Health Clinical Trial Services to recruit diabetes, chronic kidney disease patients]
In addition to the CVS Health Ventures investment, Aetna, a CVS Health company, is collaborating with Amalgam at select health systems, implementing Amalgam's EHR-integrated decision support solutions, which are designed to improve outcomes and reduce the cost of care for Aetna members.
“Digital Health solutions have become numerous in recent years; however, to be adopted at scale, they must leverage patient-specific data, fit into provider workflow and align across stakeholder incentives. Delivering actionable insights at the click of a button and driving alignment between payers and providers can help benefit patients and improve health outcomes," said Ryan Sysko, CEO of Amalgam.
[Read more: CVS Health expands leadership responsibilities]